Novel embelin‐loaded transniosomes for topical delivery: comprehensive exploration of in vitro , ex vivo and dermatokinetic assessment for anti‐cancer activity
Journal of the Science of Food and Agriculture · 2025
DOI: 10.1002/jsfa.13831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Science of Food and Agriculture, 2025. Verfasst von Abdullah S Alshetaili und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia. Hauptthemen laut MEDLINE: Benzoquinones, Skin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia.
Abstract (Originalsprache)
BACKGROUND This study systematically designed and optimised a transniosomal formulation containing embelin for skin cancer management. The transniosomes were developed using a rotary evaporation method and then optimised using a Box–Behnken design. RESULTS The optimized embelin‐loaded transniosomes (Opt‐EMB‐TNs) exhibited a vesicle size of 149.01 nm, polydispersity index of 0.184, a zeta potential of −21.14 mV, an entrapment efficiency of 75.6 ± 0.65%, drug loading of 3.36 ± 0.03% and drug release of 80.88 ± 2.55%. The antioxidant potential of Opt‐EMB‐TNs was found to be 88.54% when compared to standard ascorbic acid. Dermatokinetic studies showed a greater drug deposition in targeted skin areas with Opt‐EMB‐TN gel compared to the embelin conventional gel (EMB‐CF gel). In addition, the penetration depth study of the skin sample revealed that the transniosomal gel containing rhodamine B dye exhibited higher penetration than that of the rhodamine B dye containing hydroalcoholic solution. The efficacy of Opt‐EMB‐TNs for skin cancer was confirmed by cytotoxicity assay against the B16F10 melanoma cell line. CONCLUSION The study concluded that the Opt‐EMB‐TN gel formulation is a promising and effective topical treatment for skin cancer, demonstrating significant potential for further development and clinical application. © 2024 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
ORCID-Profile: Abdullah S Alshetaili
Förderung
- Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia
Zitieren
APA
Alshetaili, A. S., Almohizea, S., Anwer, M. K., & Riadi, Y. (2025). Novel embelin‐loaded transniosomes for topical delivery: comprehensive exploration of in vitro , ex vivo and dermatokinetic assessment for anti‐cancer activity. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.13831
Vancouver
Alshetaili AS, Almohizea S, Anwer MK, Riadi Y. Novel embelin‐loaded transniosomes for topical delivery: comprehensive exploration of in vitro , ex vivo and dermatokinetic assessment for anti‐cancer activity. Journal of the Science of Food and Agriculture. 2025. doi:10.1002/jsfa.13831
BibTeX
@article{Alshetaili2025,
author = {Alshetaili, Abdullah S and Almohizea, Salman and Anwer, Md Khalid and Riadi, Yassine},
title = {Novel embelin‐loaded transniosomes for topical delivery: comprehensive exploration of in vitro , ex vivo and dermatokinetic assessment for anti‐cancer activity},
journal = {Journal of the Science of Food and Agriculture},
year = {2025},
doi = {10.1002/jsfa.13831}
}
EUVIMED